TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
PRME

Prime Medicine, Inc.

Healthcare · Biotechnology

3.10$ +4.7% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Prime Medicine, Inc. (PRME) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 249 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PRME
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
239 194 311 260 333 298 328 279 385 343 295 249
185 143 218 171 246 212 164 121 231 181 138 97
44 42 94 56 118 182 92 54 71 63 64 47
165 122 211 163 176 190 144 102 208 178 135 95
55 0.0 0.1
45 61 68 63 143 144 221 218 223 222 218 209
39 56 24 21 38 38 34 34 35 37 36 32
11 9.3 6.8 5.2 4.5 3.6 6.9 7.3 7.7 8.1 8.5 9.0
14 20 10 4.6 5.4 11 10 6.4 9.4 8.9 12 5.8
194 133 244 197 190 153 107 61 162 121 77 40
-426 -491 -537 -592 -645 -687 -739 -792 -842 -888 -937 -980
92 97 104 119 120 119 131 129 161 149 177 177

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?